Tensions on the Korean Peninsula have been on the rise lately, as a new leader in North Korea seeks to assert his leadership by making increasingly provocative threats toward both its neighbors and the United States. In the following video, Fool markets analyst Mike Klesta talks with Fool contributor Dan Caplinger about whether U.S. investors should be worried about what's happening with North Korea.
Mike points out that the Dow Jones Industrials (DJINDICES: ^DJI ) have largely ignored the Korean threat. Dan believes that while most U.S. stocks have little exposure to the area, investors in South Korean stocks have already seen substantial losses and could continue to see further drops if the crisis escalates. Dan argues that for the most part, U.S. investors should look at U.S. companies that have business operations in South Korea to see how they plan to handle any rising tensions in the future. Moreover, investors in emerging-market ETFs need to be aware that they may have a portion of their assets invested in South Korea, although the exact amount varies among ETFs. Mike and Dan conclude that for now, the risk to the broader U.S. stock market is small, but the situation demands further attention.
Best Asian Companies To Own For 2015: Eldorado Gold Corp(EGO)
Eldorado Gold Corporation, together with its subsidiaries, engages in the discovery, exploration, development, production, and reclamation of gold properties in Brazil, the People?s Republic of China, Greece, and Turkey. It operates the Kisladag gold mine in Turkey; the Jinfeng, Tanjianshan, and White Mountain gold mines in the People?s Republic of China; and the Vila Nova iron ore mine in Brazil. The company?s development projects include the Efemcukuru gold mine in Turkey, the Eastern Dragon gold mine in the People?s Republic of China, the Perama Hill gold project in Greece, and the Tocantinzinho gold project in Brazil. As of December 31, 2010, Eldorado Gold Corporation had 18.7 million ounces of proven and probable gold reserves. The company was formerly known as Eldorado Corporation Ltd. and changed its name to Eldorado Gold Corporation in April 1996. Eldorado Gold Corporation was founded in 1992 and is headquartered in Vancouver, Canada.
Advisors' Opinion:- [By Johanna Bennett]
Analyst John Bridges and his team like Goldcorp (GG), B2Gold (BTG) and Eldorado (EGO), and feel Buenaventura (BVN) is a serious laggard with likely improved results in the second half of 2014. They write:
- [By Patricio Kehoe]
After reaching a three-month high, gold prices fell once again following the announcement of a possible strike on Syria. Considering investors are already skeptical when it comes to gold mining firms, due to their cyclical nature, Yamana Gold Inc. (AUY) and Eldorado Gold Corp (EGO) have a lot to prove.
- [By Ben Levisohn]
On an adjusted basis, Eldorado Gold (EGO) has the longest reserve/resource life amongst our coverage companies (39 years) with Goldcorp (GG) having the longest reserve/resource life (23 years) amongst the senior producers versus the group average of 22 years. Kinross Gold (KGC) and Iamgold (IAG) have the shortest adjusted reserve/resource lives amongst the senior and mid-tier producers (18 and 14 years respectively). On a percentage basis, the companies most affected by the adjustment are New Gold (NGD) and Iamgold which both saw reserve/resource lives fall by 47% however, we note that despite the adjustment,�New Gold still has the second longest reserve/resource life in our group (37 years). Newmont Mining was the least affected by the adjustments with reserve/resource life declining by only 12% to 22 years from 25 years.
- [By alicet236]
Eldorado Gold Corp. (EGO) Reached the Five-Year Low of $5.66
The prices of Eldorado Gold Corp. (EGO) shares have declined to close to the five-year low of $5.66, which is 75.4% off the five-year high of $22.12. Eldorado Gold Corp. is owned by six Gurus we are tracking. Among them, five have added to their positions during the past quarter. Two reduced their positions. Eldorado Gold Corp. is a gold exploration, development, mining and production company. Eldorado Gold Corp. has a market cap of $4.04 billion; its shares were traded at around $5.66 with a P/E ratio of 42.60 and P/S ratio of 6.65. The dividend yield of Eldorado Gold Corp. stocks is 2.09%. Eldorado Gold Corp. had an annual average earnings growth of 15.50% over the past five years.
Hot Prefered Companies To Invest In Right Now: Solar Thin Films Inc (SLTZ)
Solar Thin Films, Inc. is engaged in the business of designing, manufacturing and installation of thin-film amorphous silicon (a-Si) photovoltaic manufacturing equipment. The equipment is used in plants that produce photovoltaic thin-film a-Si solar panels or modules. The Company operates through its wholly owned subsidiary, Kraft Elektronikai Zrt (Kraft). Kraft is engaged in the design, development, manufacture, and installation of a-Si photovoltaic manufacturing equipment. The primary buyers of photovoltaic thin-film manufacturing equipment are businesses, as well as investment partnerships, engaged in the production of photovoltaic thin-film modules. In May 2010, the Company acquired Atlantis Solar LLC. In May 2013, Solar Thin Films Inc acquired Quality Resource Technologies Inc. In October 2013, Solar Thin Films Inc announced the sale of all of its ownership stake of Hungarian subsidiary, Kraft, R.t. (Kraft), to GJR Collectibles LLC.
Kraft has been providing equipment that is incorporated into a single manufacturing line capable of manufacturing a-Si solar modules that produce approximately 5megawatt (MW) of solar power annually. The Company focuses, directly and through joint ventures or alliances with other companies or governmental agencies, to sell equipment for and participate financially in solar power facilities using thin film a-Si solar modules or metallurgical and other crystalline solar modules as the power source to provide electricity to municipalities, businesses and consumers.
The Company competes with Applied Materials and Oerlikon.
Advisors' Opinion:- [By Peter Graham]
Small cap stocks Alliance Creative Group Inc (OTCMKTS: ACGX), Dale Jarrett Racing Adventure Inc (OTCMKTS: DJRT), Inscor Inc (OTCMKTS: IOGA) and Solar Thin Films Inc (OTCMKTS: SLTZ) have all been getting some attention lately in various investment newsletters and it should come as no surprise that two out of four of these stocks have been the subject of paid promotions ��which tend to benefit traders. However, two out of four of these stocks also have pretty good financials for being small cap OTC stocks and that might make them attractive to investors with a long term time horizon. So which of these stocks might make traders some profits in the short term and investors some profits over the longer term? Here is a closer look to help you decide:
Hot Prefered Companies To Invest In Right Now: Mobile TeleSystems (MBT)
Mobile TeleSystems OJSC, together with its subsidiaries, provides telecommunications services primarily in the Russian Federation, Ukraine, Uzbekistan, Armenia, and Belarus. The company provides a range of mobile and fixed line voice and data telecommunications services, including transmission, broadband, pay-TV, and various value-added services; and sells equipment and accessories. It also offers network access services, including mobile cellular voice and data communication services; automatic roaming services; GPRS and Internet access services; and 3G technology. In addition, the company�s services include the design, construction, and installation of local voice and data networks capable of interconnecting with fixed line operators; installation and maintenance of cellular payphones; lease of digital communication channels; and provision of access to open computer databases and data networks, including the Internet, as well as video conferencing, and fixed, local, and long-distance telecommunications services. Its value-added services comprise call divert/forwarding, caller ID and anti-caller ID display, conference calling, WiFi, GPRS, intelligent call assistant, APN remote access point, fixed mobile convergence, enhanced data rates for GSM Evolution, call barring, SMS, mobile office, voicemail, mobile banking, wireless application protocol, MTS-Connect, SIM-browser, point-to-point transfer, unstructured supplementary services data, downlink packet access, mobile TV, call waiting, MMS, ring tones, missed call alert, itemization of monthly bills, information and directory, international access, WEB and WAP portal, customer care system, ring back tone, collect call, and location-based services. As of December 31, 2011, the company had a mobile subscriber base of approximately 101.14 million. It has a strategic partnership with Vodafone. The company was founded in 1993 and is headquartered in Moscow, the Russian Federation.
Advisors' Opinion:- [By Jake L'Ecuyer]
Telecommunications services sector was the leading decliner in the US market today. Telecommunications services stocks dropped 0.43% in today's trading. Among the stocks, Mobile Telesystems OJSC (NYSE: MBT) was down more than 4.8%, while Telecom Argentina SA (NYSE: TEO) tumbled around 2.5%.
- [By Dan Radovsky]
VimpleCom, a joint venture of Norwegian telecom Telnor and the Russian Alfa Group, operates under the BeeLine brand in Russia. BeeLine has joined the two other ex-iPhone carrying Russian heavyweight mobile carriers, Megafon and Mobile TeleSystems (NYSE: MBT ) , and not renewed its iPhone contract with Apple.
- [By MONEYMORNING.COM]
For one thing, Russian telecom firms VimpelCom Ltd. (Nasdaq ADR: VIP) and Mobile TeleSystems OJSC (NYSE ADR: MBT) each do "considerable business" in Ukraine, the trade journal reports. For instance, MTS had about 22.4 million subscribers in that country as of September, making it Ukraine's No. 2 mobile provider, Reuters reported. And VimpelCom gets about 8% of its cash flow from that market.
- [By Rich Smith]
Over in Russia, market-leading cell phone provider Mobile TeleSystems (NYSE: MBT ) has just confirmed that, as of 2012, it no longer sells Apple's (NASDAQ: AAPL ) new iPhone models to its customers directly. The company does still stock, and sell, some older iPhone models. But for iPhone5 and on up, MTS now answers phone calls from Apple with a Spasibo, ne nada. ("Thanks, but no thanks.")
Hot Prefered Companies To Invest In Right Now: Poly Shield Technologies Inc (SHPR)
Poly Shield Technologies Inc. (Poly Shield), incorporated on March 2, 2000, is a research, development and marketing company providing environmental, energy saving and durability solutions. The Company's are designed and manufactured under the advanced bio-scrubber technology and includes a line of protective fluoropolymer coatings. Poly Shield�� fluoropolymer products are manufactured at a production facility in Florida. Poly Shield�� manufactured fluoropolymer coatings are used in a number of different industries including marine, aerospace, oilfield, industrial, commercial, and residential applications. In addition, Poly Shield offers a line of antimicrobial coatings for use in hospital or food industries. In December 2013, Poly Shield Technologies Inc sold New World Technologies Group, Inc. to Viveros.
The Company's products include bio-scrubber, supershield, superiorshield and microshield. Its products are used in aerospace, cruise ship lines, marine, military, oil, and energy production industries. The Company's bio-scrubber is designed to remove alkali metals from fuel in an effort to protect gas turbines from high temperature corrosion. The technology has been installed on active ships within the cruise line industry.
SuperShield is a fluoropolymer coating that is formulated to work with a variety of residential, commercial, industrial and marine applications. It is a fluoroplymer resin that offers weathering ability and the choice of temperature curing. Its flagship product, SuperShield 100, containing fluoropolymer resins provides up to a 50 year service life on a steel and metal surfaces. Its SuperShield S is superhydrophobic and superoleophobic, with characteristic complex micro and nanoscopic surface, which minimizes adhesion. SuperShield S100 is also superhydrophobic and superoleophobic. SuperShield S100 is provides 50 year service life. The ultimate anti-fouling coating for ship hulls, oilfield rigs, heavy equipment, airplanes, bridges, etc.
! SuperiorShield is protective and energy saving roof coatings. Its superiorShield coating reduces heat transfer through infrared radiation, conduction and convection. SuperiorShield has the capability to reflect 90% of the suns ultraviolet (UV) rays.
MicroShield is a anti-microbial coating. MicroShield is an active antibacterial destroying the cell membrane and inducing oxidative deoxyribonucleic acid (DNA) and protein damage of microbes. It also acts as a bacteriostat, virostat and fungistat, inhibiting bacterial, viral and fungal growth.
Advisors' Opinion:- [By Peter Graham]
Small cap stocks Soul and Vibe Interactive Inc (OTCBB: SOUL), Globalstar, Inc (OTCMKTS: GSAT) and Poly Shield Technologies Inc (OTCBB: SHPR) have been getting some attention lately in various investment newsletters or investor alerts with at least two of these stocks being the subject of some sort of paid stock promotional or investor relations type of activities. With that in mind, just how hot are these three small cap stocks for investors or traders? Here is a quick reality check:
Hot Prefered Companies To Invest In Right Now: Huaneng Power International Inc (HNP)
Huaneng Power International, Inc. is principally engaged in the investment, construction, operation and management of power plants. The Company�� electricity generation business covers Northeast China Grid, North China Grid, Northwest China Grid, East China Grid, Central China Grid and South China Grid, as well as grid in Singapore. The Company�� power plants are mainly located in Shandong province, Liaoning province, Zhejiang province, Guangdong province, Jiangsu province, Hebei province, Fujian province, Jiangxi province, Chongqing city, Gansu province, Beijing city and Shanghai city, among others. As of December 31, 2010, the Company had a wholly owned power operation subsidiary in Singapore.
The Company�� Huaneng Dalian Power Plant (Dalian Power Plant) is located on the outskirts of Dalian, on the coast of Bohai Bay. Dalian Power Plant, including Phase I and Phase II, has an installed capacity of 1,400 megawatts and consists of four 350 megawatts coal-fired units. Dalian Power Plant typically stores 200,000 tons of coal onsite. Dalian Power Plant sells all its electricity through the Liaoning Electric Power Co., Ltd. and the Northeastern Power Grid. Electricity generated by Dalian Power Plant is delivered to the Liaoning Provincial Power Grid. Huaneng Dandong Power Plant (Dandong Power Plant) is located on the outskirts of the city of Dandong in Liaoning. Dandong Power Plant comprises two 350 megawatts coal-fired units. All the electricity generated by Dandong Power Plant is delivered to the Liaoning Provincial Power Grid and is sold through the Liaoning Electric Power Co., Ltd. and the Northeastern Power Grid.
Huaneng Yingkou Power Plant (Yingkou Power Plant) is located in Yingkou City in Liaoning Province. Yingkou Power Plant Phase I has an installed capacity of 640 megawatts and consists of 2x320 megawatts supercritical coal-fired generating units. Yingkou Power Plant sells all its electricity through Liaoning Electric Power Co., Ltd. and the Northeastern Power ! Grid. Electricity generated by Yingkou Power Plant is delivered to the Liaoning Provincial Power Grid. The Company�� construction projects in the Liaoning Province include the Yingkou Power Plant Phase II, which is planned to consist of two 600 megawatts coal-fired generating units. The Company owns 100% equity interests in this project.
Power Plant in Fujian Province
The Company�� Huaneng Fuzhou Power Plant (Fuzhou Power Plant) is located on the south bank of the Min River, southeast of the city of Fuzhou. Fuzhou Power Plant, including Phase I and Phase II, has an installed capacity of 1,400 megawatts and consists of four 350 megawatts coal-fired units. All the electricity sales of Fuzhou Power Plant are made through the Fujian Electric Power Company, Ltd. Electricity generated by Fuzhou Power Plant is delivered to the Fujian Provincial Power Grid.
Power Plant in Hebei Province
Huaneng Shangan Power Plant (Shangan Power Plant) is located on the outskirts of Shijiazhuang. Shangan Power Plant has been developed in two separate expansion phases. The Shangan Power Plant Phase I has an installed capacity of 700 megawatts and consists of two 350 megawatts coal-fired units. Shangan Power Plant sells all its electricity through the Hebei Electric Power Corporation. Electricity generated by Shangan Power Plant is delivered to the Hebei Provincial Power Grid. Shangan Power Plant Phase III is planned to consist of two 600 megawatts coal-fired generating units. The Company owns 100% equity interests in this project.
Power Plants in Jiangsu Province
Huaneng Nantong Power Plant (Nantong Power Plant) is located in the city of Nantong. Nantong Power Plant, including Phase I and Phase II, has an installed capacity of 1,404 megawatts, and consists of two 352 megawatts and two 350 megawatts coal-fired units. Nantong Power Plant sells all its electricity through the Jiangsu Electric Power Company. Electricity generated by Nantong Power Pl! ant is de! livered to the Jiangsu Provincial Power Grid. The Company�� Huaneng Nanjing Power Plant (Nanjing Power Plant) has an installed capacity of 640 megawatts consisting of two 320 megawatts coal-fired units.
The Huaneng Taicang Power Plant (Taicang Power Plant) is located in the vicinity of Suzhou, Wuxi and Changzhou in the Jiangsu Province. Taicang Power Plant is an ancillary facility of the China-Singapore Suzhou Industrial Park and has a total planned capacity of 1,200 megawatts. Taicang Power Plant Phase I consists of 2 x 300 megawatts coal-fired generating units. Taicang Phase II Expansion consists of two 600 megawatts coal-fired generating units. The Huaneng Huaiyin Power Plant (Huaiying Power Plant) is located in the Centre of the Northern Jiangsu Power Grid. The plant has 2 x 220 megawatts coal-fired generating units.
Power Plants in Shanghai Municipality
Huaneng Shanghai Shidongkou First Power Plant (Shidongkou I) is located in the northern region of the Shanghai Power Grid. The plant comprises 3 x 325 megawatts, 1 x 300 and 1 x 320 coal-fired generating units, and has a total installed capacity of 1,270 megawatts. Electricity generated by Shidongkou I is delivered to the Shanghai Municipal Power Grid. Huaneng Shanghai Shidongkou Second Power Plant (Shidongkou II) is located in the northern suburbs of Shanghai. Shidongkou II has an installed capacity of 1,200 megawatts and consists of two 600 megawatts coal-fired supercritical units.
Power Plants in Guangdong Province
Located on the outskirts of the city of Shantou, the Huaneng Shantou Oil-Fired Power Plant (Shantou Power Plant) was set up with the support of the Shantou municipal government and the Guangdong provincial government. In 2007, Shantou Power Plant Phase I consisted of two 300 megawatts coal-fired units. The Company�� construction project in Guangdong Province consists of the Huaneng Haimen Power Plant (Haimen Power Plant), which is planned to consist of two 1,000 mega! watts gen! erating units with a total installed capacity of 2,000 megawatts. The Company owns 100% equity interest in this project.
Power Plants in Shandong Province
Huaneng Dezhou Power Plant (Dezhou Power Plant) is located in Dezhou City, near the border between Shandong and Hebei Provinces. Dezhou Power Plant consists of three Phases, with Phases I consisting of one 320 megawatts and one 330 megawatts coal-fired generating units, Phase II consisting of two 300 megwatts coal-fired generating units, and Phase III consisting of two 700 megawatts coal-fired generating units. Dezhou Power Plant sells its electricity through Shandong Electric Power Corporation. Electricity generated by Dezhou Power Plant is delivered to the Shandong Provincial Power Grid. Huaneng Jining Power Plant (Jining Power Plant) is located in Jining City, near the Jining load Centre and near numerous coal mines.
Huaneng Weihai Power Plant (Weihai Power Plant) is located approximately 16 kilometers southeast of Weihai City, on the shore of the Bohai Gulf. The Company holds a 60% interest in Weihai Power Plant, the remaining 40% interest of which is owned by Weihai Power Development Bureau (WPDB). Weihai Power Plant, developed in two phases, consists of four coal-fired generating units with an aggregate design capacity of 850 megawatts. Huaneng Xindian Power Plant (Xindian Power Plant) is located in Zibo Municipality of Shandong Province.
Power Plants in Zhejiang Province
Huaneng Changxing Power Plant (Changxing Power Plant) is located at the intersection of Zhejiang Province, Jiangsu Province and Anhui Province. Changxing Power Plant has one 125 megawatts and one 135 megawatts coal-fired generating units. Changxing Power Plant sells its electricity to Zhejiang Provincial Electric Power Company. The Yuhuan Power Plant is located in Taizhou of Zhejiang Province and consists of two 1,000 megawatts ultra-supercritical, coal-fired generating units with a total installed capacity of ! 2,000 meg! awatts.
Power Plant in Shanxi Province
Huaneng Yushe Power Plant (Yushe Power Plant) is located in Yushe County of Shanxi Province. Yushe Power Plant Phase I has an installed capacity of 200 megawatts and consists of two 100 megawatts coal-fired generating units. Yushe Power Plant sells all its electricity through the Shanxi Electric Power Corporation. Electricity generated by Yushe Power Plant is delivered to the Shanxi Provincial Power Grid.
Power Plant in Henan Province
Qinbei Power Plant is located in Jiyuan Municipality of Henan Province. Its installed capacity is 2,400 megawatts, which consists of four 600 megawatts supercritical coal-fired generating units.
Power Plant in Jiangxi Province
Huaneng Jinggangshan Power Plant (Jinggangshan Power Plant) is located in Jian City of Jiangxi Province, and has an installed capacity of 600 megawatts and consists of two 300 megawatts coal-fired generating units. Jinggangshan Power Plant sells its electricity through the Jiangxi Electric Power Corporation. Electricity generated by it is delivered to the Jiangxi Provincial Power Grid.
Power Plant in Hunan Province
Huaneng Yueyang Power Plant (Yueyang Power Plant) is located in Yueyang City of Hunan Province. Yueyang Power Plant Phase I has an installed capacity of 725 megawatts and consists of two 362.5 megawatts sub-critical, coal-fired generating units. Yueyang Power Plant Phase II consists of two coal-fired generating units with installed capacity of 600 megawatts. Yueyang Power Plant sells its electricity through the Hunan Electric Power Corporation. Electricity generated by Yueyang Power Plant is delivered to the Hunan Provincial Power Grid.
Power Plant in Chongqing Municipality
Huaneng Luohuang Power Plant (Luohuang Power Plant) is located in Chongqing Municipality. Each of Phase I and Phase II of Luohuang Power Plant has an installed capacity of 720 megawatts and consists ! of two 36! 0 megawatts coal-fired generating units. Luohuang Power Plant Phase III consists of two 600 megawatts coal-fired generating units with an installed capacity of 1,200 megawatts.
Power Plant in Gansu Province
Huaneng Pingliang Power Plant (Pingliang Power Plant) is located in Pingliang City of Gansu Province. It has an installed capacity of 1,200 megawatts and consists of four 300 megawatts coal-fired generating units.
Advisors' Opinion:- [By Jake L'Ecuyer]
Leading and Lagging Sectors
Friday morning, the utilities sector proved to be a source of strength for the market. Leading the sector was strength from Huaneng Power International (NYSE: HNP) and Pure Cycle (NASDAQ: PCYO). In trading on Friday, healthcare shares were relative laggards, down on the day by about 0.28 percent. - [By Jake L'Ecuyer]
Leading and Lagging Sectors
Friday morning, the utilities sector proved to be a source of strength for the market. Leading the sector was strength from Huaneng Power International (NYSE: HNP) and Exelon (NYSE: EXC). In trading on Friday, telecommunications services shares were relative laggards, down on the day by about 0.01 percent. - [By Jake L'Ecuyer]
Utilities sector gained 0.78 percent in the US market today. Among the utilities stocks, Huaneng Power International (NYSE: HNP) was down more than 1.4 percent, while UIL Holdings (NYSE: UIL) tumbled around 0.7 percent.
Hot Prefered Companies To Invest In Right Now: inContact Inc.(SAAS)
inContact, Inc. provides cloud-based contact center software services and network connectivity in the United States. Its solutions include inContact ACD, an automatic call distributor; inContact CTI, a computer telephony integration that integrates with customer data servers to provide agents pre-populated customer data; inContact IVR, an interactive voice response solution to create specialized call flows; and inContact Integrations for integration of various hardware and software solutions already in place at customer sites. The company also offers inContact ECHO that gathers the opinion of the customer and presents the analysis of the feedback directly to supervisors and agents; inContact Workforce Management, which forecasts demand, schedules workforce, analyzes and optimizes staffing, and reports real-time adherence in contact centers; inContact Quality Monitoring that provides insights into agent performance and customer satisfaction; and InContact Screen Recording, which provides compliance level screen recording functionality for voice channel interactions. In addition, it provides inContact eLearning that offers targeted, prioritized training, communications, and testing to the agent?s desktop during dips in call volumes; and inContact Network Connectivity, which includes time division multiplexing and voice over Internet protocol (VoIP) connectivity, and toll-free and local-number services. Further, inContact, Inc. offers professional services, as well as operates as a domestic and international long distance reseller and aggregator. The company was formerly known as UCN, Inc. and changed its name to inContact, Inc. in January 2009. inContact, Inc. was founded in 1994 and is headquartered in Salt Lake City, Utah.
Advisors' Opinion:- [By James Miller Phd]
Within the cloud computing applications, Salesforce has become a leading supplier and platform vendor, positioning itself in a strong position among other cloud application providers. Currently, through Sales Cloud, the company�� most popular product, it has succeeded in expanding its addressable market towards the purchase of Service Cloud as well. Providing different on-demand Software-as-a-Service (SaaS), such as the Sales Cloud, Service Cloud and Chatter applications, it allows customers to improve communication and sales to their respective customers. Moreover, it offers other platforms such as The Force.com Platform, or Heroku Platform, and developer tools like Database.com and The AppExchange, enabling its users to customize its applications.
- [By John Udovich]
Small cap cloud contact software provider Five9 Inc (NASDAQ: FIVN) saw a small pop when it debuted in an IPO last Friday but its now trended back down to its debut price, meaning its worth taking a closer look at the stock along with some potential peers or benchmarks like Incontact Inc (NASDAQ: SAAS), eGain Corp (NASDAQ: EGAN) and LivePerson, Inc (NASDAQ: LPSN).
Hot Prefered Companies To Invest In Right Now: Cancer Genetics Inc (CGIX)
Cancer Genetics, Inc. (CGI), incorporated on April 8, 1999, is an early-stage, diagnostic company. The Company focuses on developing and commercializing genomic tests and services to improve the diagnosis, prognosis and response to treatment (theranosis) of cancer. These cancers include hematological, urogenital and human papillomavirus (HPV)-associated cancers. It provides its tests and services to oncologists and pathologists at hospitals, cancer centers, and physician offices. In January 2012, the Company received CLIA approval for MatBA-SLL, its microarray for risk stratification in small lymphocytic lymphoma (SLL). In February 2013, the Company received CLIA approval for MatBA-DLBCL, its microarray for diagnosis, prognosis and patient monitoring in diffuse large B cell lymphoma (DLBCL). In addition, the Company is developing a series of other genomic tests in its core oncology markets. The Company develops and produces two types of deoxyribonucleic acid (DNA)-based genomic tests: microarrays and probes.
The Company is in the final stages of validating MatBATM-SLL for risk stratification in small lymphocytic lymphoma (SLL), a subset of CLL that presents as a mass, with Memorial Sloan-Kettering Cancer Center and Long Island Jewish / North Shore Hospital. The Company is also internally clinically validating the MatBATM microarray in a variety of additional lymphoma subtypes, including mantle-cell lymphoma (MCL), follicular lymphoma (FL), and diffuses large B cell lymphoma (DLBCL). Its MatBATM array has been designed to measure genetic markers at 80 specific genomic sites where genetic alterations are associated with mature B cell neoplasms.
CGI is also developing microarray tests for the diagnosis, prognosis and theranosis of a range of urogenital cancers. These include the UroGenRA microarray for kidney, prostate and bladder cancers and the UGenRA microarray for endometrial (lining of the uterus), ovarian and cervical cancers. UroGenRA detects genomic changes in over 100 r! egions of the human genome with potential diagnostic and/or prognostic value in one or more of these types of cancer. It has initiated clinical validation for UroGenRA targeting kidney and prostate cancers in collaboration with Memorial Sloan-Kettering Cancer Center. Its UGenRA microarray has been designed as a platform to detect genomic changes occurring in 83 regions of the human genome that have been linked to endometrial, ovarian and cervical cancers In addition, it develop and manufacture a portfolio of fluorescence in situ hybridization (FISH) based DNA probes focused on blood-based and solid cancers that it sell outside the United States. The Company laboratory services include: Oncology Testing Services, which are based on its microarray tests and are available only in its clinical laboratory; Esoteric Oncology Testing Services, which it offers a suite of esoteric oncology testing services for hematological, urogenital and HPV-associated cancers, and Clinical Trial Services, which also utilize its clinical laboratory to provide clinical trial services to biopharmaceutical companies and clinical research organizations.
Hematological Cancer Arrays: MatBA-CLL/SLL, Other Mat-BA and LeukA
MatBA is an oligonucleotide-based microarray the Company developed for the analysis of genomic alterations in mature B-cell neoplasms to determine prognosis and theranosis. MatBA incorporates a common architecture of specific genomic regions that can be applied across the seven major mature B-cell neoplasms. As a group, hematologic cancers (cancers of the blood, bone marrow or lymph nodes) display clinical, pathologic and genetic complexity. Importantly, the clinical course of the six main subtypes of these neoplasms ranges from indolent (follicular lymphoma) to aggressive (diffuse large B-cell lymphoma, mantle cell lymphoma and multiple myeloma), or mixed (chronic lymphocytic leukemia/small lymphocytic lymphoma, or CLL/SLL).
MatBA is designed to detect genomic copy number chan! ges in ma! ture B-cell neoplasms. The test relies on the comparative genomic hybridization of fluorescently differentially-labeled normal DNA and DNA extracted from the cancer specimen (array-CGH). Array-CGH utilizes minimal biopsy material and uses DNA as the analyte (the component whose properties are being measured). MatBA was custom-designed to represent 80 regions of the human genome which have diagnostic and/or prognostic value in one or more of the mature B-cell neoplasm subtypes as identified through our research and analysis efforts. Unlike other technologies such as FISH, array-CGH using MatBA simultaneously permits the detection of genomic gains and losses at multiple locations on a chromosome (loci) that characterize the mature B-cell neoplasm subtypes. For each subtype of B-cell neoplasm, cohorts of specimens with full clinical annotation are evaluated using MatBA to identify associations between single and weighted combinations of genomic gains/losses and clinically relevant endpoints.
The Company offers the application of MatBA for prognostication in one subtype of mature B-cell neoplasm, CLL, where about half of patients experience indolent disease, or slow progression, and the remaining half, a relatively aggressive progression. MatBA-CLL provides genetic-based information to guide clinical management of this disease. In January 2012, MatBA-SLL was approved under CLIA and accordingly may now be offered as an LDT by its laboratory. In January 2013, this assay received approval by CLIA and New-York State for clinical use, and accordingly may now be offered as an LDT by our reference laboratory.
During the year ended December 31, 2012, the Company had similar development of MatBA as a prognostic tool in two of the other main subtypes of mature B-cell lymphomas, namely DLBCL and FL. FL is characterized by a slow progression that in up to approximately 60% of cases transforms to DLBCL, an aggressive lymphoma. Prognostic and theranostic biomarkers of therapeutic options are req! uired for! these diseases.
Urogenital cancer arrays: UroGenRA, UGenRA
The UroGenRA microarray provides diagnostic and prognostic analysis for kidney, bladder and prostate cancer. Its initial launch, UroGenRA-Kidney targets kidney cancer. It also develops extensions of UroGenRA for bladder and prostate cancers. UGenRA provide diagnostic, prognostic and theranostic information for the primary gynecological cancers, cervical, ovarian and endometrial. UroGenRA is a CGH-based array which serves as a platform for the diagnosis, prognosis and theranosis of kidney, prostate and bladder cancers. It represents 101 regions of the human genome potentially with diagnostic, prognostic and/or theranostic value in one or more of these types of cancers. UroGenRA-Kidney For kidney cancer, UroGenRA is specifically designed to classify renal tumors into the four main subtypes (clear cell, papillary, chromophobe and oncocytoma), which is critical to patient management and treatment protocols.
UroGenRA-Prostate for prostate cancer, UroGenRA use prostate core/needle biopsy to assess genomic variability of the cancer and help in the identification of biomarkers for assessment of the risk of recurrence, to assess treatment options for intermediate risk patients, and to explore the genomic aberrations of circulating tumor cells. UroGenRA-Prostate is in the commercial development stage. UroGenRA-Bladder is a diagnosed bladder cancers are defined by the fact or extent of invasion of the muscle. UroGenRA-Bladder is in the clinical development stage.
UGenRA for Endometrial, Ovarian and Cervical Cancers
UGenRA is designed as a platform to detect gains and losses of genomic material in 83 regions of the chromosome associated with responses to particular therapies in patients with endometrial, ovarian and cervical. UGenRA-Endometrial Endometrial cancer is common cancer in women in the United States. In this disease, endometrial hyperplasia is a precursor lesion of endometr! ioid endo! metrial carcinoma (EEC). UGenRA Endometrial is in the clinical development stage.
UGenRA-Ovarian is cases of ovarian cancer. UGenRA Ovarian is in the clinical development stage. As of December 31, 2012, UGenRA-Cervical was approximately 11,270 cases of cervical cancer diagnosed and approximately 4,290 deaths from cervical cancer in the United States. UGenRA Cervical is in the clinical development stage.
Advisors' Opinion:- [By RedChip]
In an amended S-1 filed with the SEC this morning, Cancer Genetics, Inc. (NASDAQ: CGIX) added two new firms to its offering syndicate and upped its capital raise 25% to $50 million. With the underwriters��overallotment, the total raise is now forecasted to reach as much as $57.5 million.
- [By RedChip]
Cancer Genetics (NASDAQ: CGIX), an emerging leader in DNA-based cancer diagnostics, priced a $15 million secondary offering and began trading on the NASDAQ today.
The offering will bring in a sizable cash infusion to CGIX, setting the stage for continued expansion of the Company�� sales and marketing efforts, as well as further product development and commercialization. In addition, it will enable the Company to fund its joint venture investment with Mayo Clinic and retire mezzanine financing. - [By John Udovich]
Cancer has been one of the hotter segments of the sizzling biotech sector this year with small cap cancer stocks�Genetics Inc (NASDAQ: CGIX), GTx, Inc (NASDAQ: GTXI) and MetaStat Inc (OTCMKTS: MTST) being among those involved in cancer research or treatment producing noteworthy news for investors to digest. Just consider the following:
No comments:
Post a Comment